비씨월드제약 사업보고서 (2021.12)
1. 요약재무정보

당사는 주식회사의 외부감사에 관한법률 제13조 1항1호에서 규정하고 있는 국제회계기준위원회의 국제회계기준을 채택하여 정한 회계처리기준인 한국채택국제회계기준에 따라 재무제표를 작성하였습니다. 가. 연결요약재무정보

(단위 : 원)

과목	제42(당)기	제41(전)기	제40(전전)기

2021년 12월말	2020년 12월말	2019년 12월말

[유동자산]	37,234,632,805	43,063,353,911	33,845,689,840

ㆍ당좌자산	4,502,521,874	12,560,812,998	3,456,010,613

ㆍ매출채권및기타매출	15,926,836,566	14,712,393,488	16,136,903,921

ㆍ재고자산	16,147,338,543	15,369,696,704	13,908,054,781

ㆍ기타유동자산	657,935,822	420,450,721	344,720,525

[비유동자산]	147,866,196,108	133,861,893,309	128,324,866,146

ㆍ투자자산	3,756,414,963	3,302,572,873	1,994,153,577

ㆍ유형자산	138,364,625,901	125,499,562,540	121,740,089,868

ㆍ무형자산	2,265,766,219	1,174,791,740	1,295,510,400

ㆍ기타비유동자산	3,479,389,025	3,884,966,156	3,295,112,301

자산총계	185,100,828,913	176,925,247,220	162,170,555,986

[유동부채]	57,092,474,507	56,159,648,971	41,445,903,752

[비유동부채]	47,118,639,804	37,197,777,228	34,753,931,424

부채총계	104,211,114,311	93,357,426,199	76,199,835,176

[지배기업지분]	82,252,930,454	84,161,106,151	85,949,853,805

ㆍ자본금	1,778,476,800	1,778,476,800	1,601,663,760

ㆍ자본잉여금	34,947,264,726	34,947,264,726	32,724,600,817

ㆍ자본조정	(771,621,170)	(771,621,170)	1,499,052,139

ㆍ기타포괄손익누계	248,541,317	100,654,351	954,720,000

ㆍ이익잉여금	46,050,268,781	48,106,331,444	49,169,817,089

[소수주주지분]	(1,363,215,852)	(593,285,130)	20,867,005

자본총계	80,889,714,602	83,567,821,021	85,970,720,810

구분	(2021.01.01 ~2021.12.31)	(2020.01.01 ~2020.12.31)	(2019.01.01 ~2019.12.31)

매출액	62,079,356,724	57,030,365,933	51,497,337,124

영업이익	(1,798,448,805)	(2,096,430,277)	(1,004,654,414)

당기순이익	(2,248,277,905)	(2,194,132,936)	(1,738,975,694)

ㆍ지배회사지분순손익	(1,478,347,183)	(1,579,980,801)	(1,552,775,587)

ㆍ소수주주지분순손익	(769,930,722)	(614,152,135)	(186,200,107)

총포괄손익	(1,824,249,922)	(1,606,753,189)	(1,637,185,694)

ㆍ지배회사지분순손익	(1,054,319,200)	(992,601,054)	(1,450,985,587)

ㆍ소수주주지분순손익	(769,930,722)	(614,152,135)	(186,200,107)

주당순이익(원)	(173)	(185)	(185)

연결에 포함된 회사수	1	1	1

나. 별도요약재무정보(단위 : 원)

과목	제42(당)기	제41(전)기	제40(전전)기

2021년 12월말	2020년 12월말	2019년 12월말

[유동자산]	38,323,993,872	44,300,496,258	32,289,799,149

ㆍ당좌자산	4,306,087,488	11,180,509,978	3,105,678,141

ㆍ매출채권및기타매출	19,695,344,344	21,456,453,487	16,952,131,048

ㆍ재고자산	13,819,373,505	11,475,965,608	12,026,287,701

ㆍ기타유동자산	503,188,535	187,567,185	205,702,259

[비유동자산]	115,237,474,070	100,701,015,034	96,901,909,729

ㆍ투자자산	3,756,414,963	3,302,572,873	2,015,020,666

ㆍ유형자산	107,751,068,428	94,021,043,850	90,987,613,997

ㆍ무형자산	2,077,095,551	1,017,857,740	1,295,510,400

ㆍ기타비유동자산	1,652,895,128	2,359,540,571	2,603,764,666

자산총계	153,561,467,942	145,001,511,292	129,191,708,878

[유동부채]	38,501,443,240	38,224,757,642	26,977,159,639

[비유동부채]	31,443,872,944	22,022,359,996	16,264,695,434

부채총계	69,945,316,184	60,247,117,638	43,241,855,073

ㆍ자본금	1,778,476,800	1,778,476,800	1,601,663,760

ㆍ자본잉여금	34,947,264,726	34,947,264,726	32,724,600,817

ㆍ자본조정	(771,621,170)	(771,621,170)	1,499,052,139

ㆍ기타포괄손익누계	248,541,317	100,654,351	954,720,000

ㆍ이익잉여금	47,413,490,085	48,699,618,947	49,169,817,089

자본총계	83,616,151,758	84,754,393,654	85,949,853,805

종속ㆍ관계ㆍ공동기업투자주식의 평가방법	지분법	지분법	지분법

구분	(2021.01.01 ~2021.12.31)	(2020.01.01 ~2020.12.31)	(2019.01.01 ~2019.12.31)

매출액	60,847,744,038	57,425,317,939	52,238,452,694

영업이익	413,955,283	(410,058,272)	(188,370,455)

당기순이익	(708,413,382)	(986,693,298)	(1,552,775,587)

기타포괄손익	424,027,983	587,379,747	101,790,000

ㆍ재분류되지 않는 손익	424,027,983	587,379,747	101,790,000

총포괄손익	(284,385,399)	(399,313,551)	(1,450,985,587)

주당순이익(원)	(83)	(116)	(201)